IP Library Granted Patent US 11,857,258
Granted Patent B2
US 11,857,258 · App. 17/228,458 · Granted Jan 2, 2024

Vergence recovery convalescence using dynamic vergence testing platform including 3D head mounted display system with integrated eye tracking technology

Inventors: Alexander D. Kiderman (Pittsburgh, PA); Robin C. Ashmore (Pittsburgh, PA)
Assignee: NEUROLIGN USA, LLC
A61B3/113A61B3/0041G02B27/0093G02B27/017
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,857,258
App. No.
17/228,458
Granted
Jan 2, 2024
Kind
B2
Abstract

An objective testing of vergence dysfunction comprising the steps of: providing a head mounted goggle based stimulus generating eye tracking unit to the subject; presenting visual stimulus to the subject, wherein the visual stimulus is in the head mounted goggle based system and forms the optical target stimulus for at least one vergence test; obtaining objective physiologic response of the subject from the head mounted goggle unit based upon each of the visual stimulus presented to the subject in each test; and using the objective physiologic responses to diagnose the presence of vergence dysfunction. On objective portable head mounted goggle based stimulus generating eye tracking unit for vergence testing is discloses as is a method of method of vergence recovery convalescence.

Claims (27)

1. A method of vergence recovery convalescence using dynamic vergence testing platform including 3d head mounted display system with integrated eye tracking technology comprising the steps of:

A. providing a head mounted goggle based stimulus generating eye tracking unit to the subject;

B. presenting visual stimulus to the subject, wherein the visual stimulus is in the head mounted goggle based system and forms the optical target stimulus for at least one vergence test, wherein at least one vergence test comprises at least one of i) a saccade vergence test that includes presenting targets at different virtual depths in a punctuated fashion whereby sudden shifts in target position are presented to the subject followed by delays where the targets are stationary, ii) a smooth pursuit vergence test that includes presenting a continuously, smoothly transitioning movement of the stimuli configured to create the appearance of a target gradually moving toward or away from the subject in the virtual depth space, iii) an offset vergence test wherein the optical target stimulus is presented in a line offset from the midline between the subject's eyes;

C. obtaining objective physiologic response of the subject from the head mounted goggle unit based upon each of the visual stimulus presented to the subject in each test; and

D. Presenting at least select physiologic responses to the subject; and

E. Selectively repeating steps B-D.

2. The method of vergence recovery convalescence using dynamic vergence testing platform including 3d head mounted display system with integrated eye tracking technology comprising the steps of:

A. providing a head mounted goggle based stimulus generating eye tracking unit to the subject;

B. presenting visual stimulus to the subject, wherein the visual stimulus is in the head mounted goggle based system and forms the optical target stimulus for at least one vergence test, wherein the optical target stimulus is presented in the context of background stimuli configured to appear as 3 dimensional objects that surround and orientate the target stimulus in virtual 3 dimensional space;

C. obtaining objective physiologic response of the subject from the head mounted goggle unit based upon each of the visual stimulus presented to the subject in each test; and

D. Presenting at least select physiologic responses to the subject; and

E. Selectively repeating steps B-D.

3. The method of vergence recovery convalescence using dynamic vergence testing platform according to claim 2 wherein the background stimuli is in the form of a box tunnel.

4. The method of vergence recovery convalescence using dynamic vergence testing platform according to claim 2 , wherein at least one vergence test comprises a saccade vergence test that includes presenting targets at different virtual depths in a punctuated fashion whereby sudden shifts in target position are presented to the subject followed by delays where the targets are stationary.

5. The method of vergence recovery convalescence using dynamic vergence testing platform according to claim 4 wherein the objective physiologic responses used to diagnose the presence of vergence dysfunction includes Left and right eye response time to saccade vergence tests.

6. The method of vergence recovery convalescence using dynamic vergence testing platform according to claim 4 wherein the objective physiologic responses used to diagnose the presence of vergence dysfunction includes Symmetry of left and right eye movement of saccade vergence tests.

7. The method of vergence recovery convalescence using dynamic vergence testing platform according to claim 4 wherein the objective physiologic responses used to diagnose the presence of vergence dysfunction includes at least one of i) Left and right eye response time to saccade vergence tests, ii) Symmetry of left and right eye movement of saccade vergence tests, iii) Amplitude of-Eye movement of saccade vergence tests, and iv) % of saccade of saccade vergence tests.

8. The method of vergence recovery convalescence using dynamic vergence testing platform according to claim 2 , wherein at least one vergence test comprises a smooth pursuit vergence test that includes presenting a continuously, smoothly transitioning movement of the stimuli configured to create the appearance of a target gradually moving toward or away from the subject in the virtual depth space.

9. The method of vergence recovery convalescence using dynamic vergence testing platform according to claim 8 wherein the smooth pursuit vergence test comprises having subjects visualized the stimulus moving towards and away in a sinusoidal pattern at about 0.1 Hz.

10. The method of vergence recovery convalescence using dynamic vergence testing platform according to claim 8 wherein the objective physiologic responses used to diagnose the presence of vergence dysfunction includes at least one of i) measures of the angle of the left and right eye with the target at the nearest point and the farthest points in its sinusoidal movement in the smooth pursuit vergence testing, ii) a measure an amplitude of eye movement in the smooth pursuit vergence testing, iii) Lag time which is a measure of the delay between target movement and tracking eye movement in the smooth pursuit vergence testing, and iv) Symmetry which is a measure of the comparison of the left and the right eye movements in the smooth pursuit vergence testing.

11. The method of vergence recovery convalescence using dynamic vergence testing platform according to claim 1 wherein at least one vergence test comprises at least the offset vergence test wherein the optical target stimulus is presented in a line offset from the midline between the subject's eyes, and wherein the offset vergence test includes aligning the target with one of the subject's eyes.

12. The method of vergence recovery convalescence using dynamic vergence testing platform according to claim 1 wherein the subject is given a threshold of physiologic response for a given deficiency in a given test.

13. The method of vergence recovery convalescence using dynamic vergence testing platform according to claim 12 wherein at least one vergence test comprises the saccade vergence test that includes presenting targets at different virtual depths in a punctuated fashion whereby sudden shifts in target position are presented to the subject followed by delays where the targets are stationary.

14. The method of vergence recovery convalescence using dynamic vergence testing platform according to claim 12 wherein at least one vergence test comprises the smooth pursuit vergence test that includes presenting a continuously, smoothly transitioning movement of the stimuli configured to create the appearance of a target gradually moving toward or away from the subject in the virtual depth space.

15. The method of vergence recovery convalescence using dynamic vergence testing platform according to claim 12 wherein the optical target stimulus is presented in the context of background stimuli configured to appear as 3 dimensional objects that surround and orientate the target stimulus in virtual 3 dimensional space.

16. The method of vergence recovery convalescence using dynamic vergence testing platform according to claim 15 wherein the background stimuli is in the form of a box tunnel.

17. The method of vergence recovery convalescence using dynamic vergence testing platform according to claimer 15 wherein at least one vergence test comprises a saccade vergence test that includes presenting targets at different virtual depths in a punctuated fashion whereby sudden shifts in target position are presented to the subject followed by delays where the targets are stationary.

Assignments (5)
SECURITY INTEREST Recorded Jul 13, 2026
From: SPRYSON, INC.
To: DOVALIS SOLIS, CLAUDIA
Reel/Frame 075253/0424 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 17, 2024
From: NEURO KINETICS, INC.
To: SPRYSON INC.
Reel/Frame 066803/0430 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 14, 2024
From: NEURO KINETICS, INC.
To: NEUROLIGN USA, LLC
Reel/Frame 066775/0256 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 5, 2022
From: NEURO KINETICS, INC.
To: NEUROLIGN USA, LLC.
Reel/Frame 061325/0437 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 12, 2021
From: KIDERMAN, ALEXANDER D.; ASHMORE, ROBIN C.
To: NEURO KINETICS
Reel/Frame 055896/0158 →
Continuity (4)
Continuation 16109485 · Aug 22, 2018
Continuation In Part PCTUS2017018862 · Feb 22, 2017
Provisional Application 62298304 · Feb 22, 2016
Related Publication 20210345874A1 · Nov 11, 2021
Cited By (1)
US 12,678,039